Utility of [18F]FDG- PET/CT in Initial Staging and Management of Patients with Esophageal Carcinoma: A Tertiary Care Center Experience.

IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Indian Journal of Nuclear Medicine Pub Date : 2024-09-01 Epub Date: 2025-01-25 DOI:10.4103/ijnm.ijnm_118_23

Sankari Kommi, Ramya Priya Rallapeta, Bala Venkat Subramanian, Lakshmi Amancharla Yadagiri, Narendra Hulikal, C Chandramaliteeswaran, Rukmangada Nandyala, Tekchand Kalawat

{"title":"Utility of [18F]FDG- PET/CT in Initial Staging and Management of Patients with Esophageal Carcinoma: A Tertiary Care Center Experience.","authors":"Sankari Kommi, Ramya Priya Rallapeta, Bala Venkat Subramanian, Lakshmi Amancharla Yadagiri, Narendra Hulikal, C Chandramaliteeswaran, Rukmangada Nandyala, Tekchand Kalawat","doi":"10.4103/ijnm.ijnm_118_23","DOIUrl":null,"url":null,"abstract":"Aim of the study: This study aims to study the utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) findings in the initial staging and management of patients with esophageal carcinoma.Materials and methods: In this prospective study, we evaluated 74 patients with a mean age of 59.4 ± 11.6 with a range of 35-86 years. Comparison between the mean and standard deviation of SUVmax of primary tumor between two histopathological groups, squamous cell carcinoma (SCC) and adenocarcinoma (AC) was done using unpaired Student's t-test. The mean of SUVmax of primary tumor in relation to localized tumor to nodal to distant metastases was assessed by ANOVA test. P <0.05 was considered statistically significant. The extent of agreement between findings of contrast-enhanced computed tomography (CECT) chest and abdomen and 18F-FDG PET/CT was done using Cohen's kappa coefficient (κ).Results: Among total n = 74 (42 males and 32 females with mean age 59.4 ± 11.4; range 35-86 years) patients, SCC was seen in 78.4% and AC in 21.6% of patients. There is a progressively increased SUVmax value of primary tumor with nodal and distant metastases. 18F-FDG PET/CT showed disease of Stage I-II in 12.1%, Stage III in 20.2%, Stage IVA in 25.6%, and Stage IVB in 41.8% patients. There is agreement between 18F-FDG PET/CT and CECT chest and abdomen in the evaluation of regional lymph nodes (37.8% vs. 36.4%; κ - 0.96), nonregional lymph nodes (24.3% vs. 20.2%; κ -0.74), and distant organ involvement (21.6% vs. 17.5%; κ -0.82). In addition, 18F-FDG PET/CT found synchronous malignancies in 4.0% of patients.Conclusion: 18F-FDG PET/CT metabolic parameters help in identifying metastatic involvement in morphologically equivocal and clinically suspicious lesions in carcinoma esophagus patients. Being a whole-body imaging modality, 18F-FDG PET/CT has inbuilt advantage to detect occult, distant metastases, and synchronous malignancies for effective staging and improving plan of clinical management.","PeriodicalId":45830,"journal":{"name":"Indian Journal of Nuclear Medicine","volume":"39 5","pages":"329-334"},"PeriodicalIF":0.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884347/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Nuclear Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijnm.ijnm_118_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/25 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

Abstract

Aim of the study: This study aims to study the utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT) findings in the initial staging and management of patients with esophageal carcinoma.

Materials and methods: In this prospective study, we evaluated 74 patients with a mean age of 59.4 ± 11.6 with a range of 35-86 years. Comparison between the mean and standard deviation of SUV_max of primary tumor between two histopathological groups, squamous cell carcinoma (SCC) and adenocarcinoma (AC) was done using unpaired Student's t-test. The mean of SUV_max of primary tumor in relation to localized tumor to nodal to distant metastases was assessed by ANOVA test. P <0.05 was considered statistically significant. The extent of agreement between findings of contrast-enhanced computed tomography (CECT) chest and abdomen and ¹⁸F-FDG PET/CT was done using Cohen's kappa coefficient (κ).

Results: Among total n = 74 (42 males and 32 females with mean age 59.4 ± 11.4; range 35-86 years) patients, SCC was seen in 78.4% and AC in 21.6% of patients. There is a progressively increased SUV_max value of primary tumor with nodal and distant metastases. ¹⁸F-FDG PET/CT showed disease of Stage I-II in 12.1%, Stage III in 20.2%, Stage IVA in 25.6%, and Stage IVB in 41.8% patients. There is agreement between ¹⁸F-FDG PET/CT and CECT chest and abdomen in the evaluation of regional lymph nodes (37.8% vs. 36.4%; κ - 0.96), nonregional lymph nodes (24.3% vs. 20.2%; κ -0.74), and distant organ involvement (21.6% vs. 17.5%; κ -0.82). In addition, ¹⁸F-FDG PET/CT found synchronous malignancies in 4.0% of patients.

Conclusion: ¹⁸F-FDG PET/CT metabolic parameters help in identifying metastatic involvement in morphologically equivocal and clinically suspicious lesions in carcinoma esophagus patients. Being a whole-body imaging modality, ¹⁸F-FDG PET/CT has inbuilt advantage to detect occult, distant metastases, and synchronous malignancies for effective staging and improving plan of clinical management.

查看原文